EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/05/2025
Back to search
Official data from USPTO
WID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WID
ST13
US500000097150184Class
5, 10, 42, 44
Filing
97150184
Registration
7307764
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/05/2025
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
12/01/2021
Registration date
02/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
03/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Zams, AT
Examiner
NELMAN, JESSE
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sola Diagnostics GmbH
Representatives
John Mueller BAKER & HOSTETLER LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic biomarker reagents for medical purposes used in connection with a cervical swab to identify gynaecologic cancers of the cervixuterine bodyovary and breast; diagnostic kits comprised of medical assays for testing bodily fluidsbodily tissue and blood for use in disease detectiongynecological cancer andin particularcervicaluterineovarian and breast cancers; diagnostic reagents in kit form consisting of kits comprised primarily of diagnostic reagents for conducting assays for medical purposes; medical in vitro diagnostic reagents for polymerase chain reaction (pcr) technologies; medical diagnostic reagents; epigenetic test kits comprising reagents for testing and analysing bodily fluidsbodily tissue and blood for the diagnosis and detection of cancer; diagnostic reagents and kits of comprised primarily of diagnostic reagents for preparing moleculesdevicesconsumablesinstruments for the generation of sequencing datagenomic datacytogenetic datacytogenomic dataepigenetic datagenome physical structure datagenome temporal relationship datagenome spatial relationship datasubnucleus structure datacytosol structure datacellular organelle datacell structure datacell morphology data for medical diagnostic use
Class 10
Medical apparatus for diagnostic testing of biological samplesbodily fluidsbody tissues and blood for the detection of cancer and disease; medical diagnostic apparatus for use in analytical tests for detecting cancer and disease from sample bodily fluidsbodily tissue and blood; instruments for making cervical smears; DNA and epigenetics testing apparatus for medical use; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of diseasedetection and identification of pathogensfor the detection of acquired and inherited genetic mutationsdetection and analysis of epigenetic alterations in relation to gynecological cancers of the cervixuterine bodyovary and breast
Class 42
Scientific research for chemicalbiochemicalbiological or bacteriological purposes; scientific research for medical purposes; scientific and medical research services; electronic data storage services; scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; scientific and medical research and development services in the field of the diagnosis of diseasedetection and identification of pathogensfor the detection of acquired or inherited genetic mutationsfor detection and analysis of epigenetic alterations; research and development in the field of biological preparations and substances for the treatmentdiagnosisdetection and prevention of cancer
Class 44
Medical diagnostic services; medical testing services relating to the diagnosis and treatment of diseases; medical diagnostic testing relating to the human body; blood testing services; biologicalchemicalbiochemicalbacteriologicalDNARNAproteinpolynucleic acid and molecular testing and analysis services and DNA/RNA sequencing services for medical purposes; consultancyadvisory and information services relating to medical research and development in the field of cancer diagnosis and detection
Publications
History of USPTO decisions and trademark events.
33 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/05/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/20/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2023
PUBO
PUBLISHED FOR OPPOSITION
12/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/29/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/19/2023
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
10/18/2023
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
10/18/2023
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
10/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/17/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/19/2023
GNFR
FINAL REFUSAL E-MAILED
07/19/2023
CNFR
FINAL REFUSAL WRITTEN
07/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2023
ALIE
ASSIGNED TO LIE
07/17/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/14/2022
GNRT
NON-FINAL ACTION E-MAILED
09/14/2022
CNRT
NON-FINAL ACTION WRITTEN
09/14/2022
DOCK
ASSIGNED TO EXAMINER
09/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2021
NWAP
NEW APPLICATION ENTERED
12/04/2021
Continuous trademark protection
Get notified about every new filing that threatens WID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.